Proscia Launches Concentriq® Embeddings and AI Toolkit to Accelerate AI-Driven Pathology and Medical Breakthroughs
Revvity's EUROIMMUN Introduces New Solution for Precise Typing of APOE Gene Linked to Alzheimer's Disease
Bristol Myers Squibb and Prime Medicine Sign $3.5 Billion Deal to Develop Ex Vivo T Cell Therapies
Precision BioSciences Advances Potential Cure for Chronic Hepatitis B with Phase 1 Clinical Trial Applications for PBGENE-HBV
Sun Pharma Inks Global Licensing Deal with Philogen for Anti-Cancer Drug Fibromun
Genentech Acquires Regor’s CDK Inhibitors and AntlerA Therapeutics to Bolster Oncology and Ophthalmology Pipeline
Mindpeak Raises $15.3 Million to Revolutionize AI-Powered Cancer Diagnostics
Aktis Oncology Announces $175 Million Series B Financing
ISCT Achieves ANAB Accreditation for Excellence in Cell and Gene Therapy Workforce Development
Precision Diagnostics with AI and Cardiogenomics for Heart Conditions
Naveris Showcases Groundbreaking Data on NavDx® Test for HPV-Driven Cancers at ASTRO 2024
Sinai Health Receives $1-Million Donation to Revolutionize Cancer Diagnostics with Digital Pathology Integration
Nanostics and OncoHelix Partner to Launch AI-Driven Prostate Cancer Test in the Middle East
QIAGEN Secures European IVDR Certification for QIAstat-Dx Syndromic Testing Systems and Assays
Bayer and AskBio Partner with Belief BioMed to Develop Liver-Targeted Gene Therapies